Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.
Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in...
Matsui, K;Yoshimoto, T;Tsutsui, H;Hyodo, Y;Hayashi, N;Hiroishi, K;Kawada, N;Okamura, H;Nakanishi, K;Higashino, K;
1997-07-01 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngThe Journal of ImmunologyUnpaywallhttp://www.deepdyve.com/lp/unpaywall/propionibacterium-acnes-treatment-diminishes-cd4-nk1-1-t-cells-but-adUG1B0MRe
Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.
Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.